Company Listing
Pathwork Diagnostics

Pathwork was developing microarray-based diagnostics to advance cancer care. The company's FDA-cleared Pathwork® Tissue of Origin Test helped to determine the origin of hard-to-identify tumours so that physicians and oncologists could optimise therapies. The company was acquired by Response Genetics in August 2013.

BACK
Location
Sunnyvale, California

Home

About Us

  1. About Us
  2. Our Team
  3. Transatlantic Reach
  4. Funds

Strategy

  1. Our Strategy
  2. Venture Capital
  3. Clinical Co‑development
  4. VIPEs
  5. Public Markets

Portfolio

  1. Portfolio Companies
  2. Case Studies

Media Centre

  1. Recent News
  2. Archived News
  3. Film

Contact

  1. Contact Us
  2. Send Us Your Proposal
Company Listing

Pathwork was developing microarray-based diagnostics to advance cancer care. The company's FDA-cleared Pathwork® Tissue of Origin Test helped to determine the origin of hard-to-identify tumours so that physicians and oncologists could optimise therapies. The company was acquired by Response Genetics in August 2013.

Location
Sunnyvale, California
BACK
 
Copyright Abingworth 2017